Obesity in patients with end-stage heart failure

被引：1
|
作者：
Krol, Bogumila [1 ]
Oprzedkiewicz, Aleksandra [2 ]
Szczurek, Wioletta [2 ]
Szygula-Jurkiewicz, Bozena [3 ]
机构：
[1] Silesian Ctr Heart Dis, Off Transplant Coordinat, Dept Cardiosurg Transplantol Vasc & Endovasc Surg, Zabrze, Poland
[2] Med Univ Silesia, Sch Med, Dept Cardiol 3, Div Dent Zabrze,Student Sci Soc, Katowice, Poland
[3] Med Univ Silesia, Sch Med, Dept Cardiol 3, Div Dent Zabrze, Katowice, Poland
来源：
KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA | 2018年 / 15卷 / 03期
关键词：
obesity; end-stage heart failure;
D O I：
10.5114/kitp.2018.78442
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Obesity poses an increasing problem in patients with end-stage heart failure (HF). The most commonly used indicator of obesity is body mass index. The value of this parameter is widely taken into consideration when selecting the best way of treatment for patients with advanced HF. The aim of this paper is to outline the recent knowledge about obesity in the abovementioned group of patients.
引用
收藏
页码：176 / 179
页数：4
相关论文
共 50 条
  • [41] Surgical approach to end-stage heart failure
    Klotz, Stefan
    Scheld, Hans H.
    CURRENT OPINION IN ANESTHESIOLOGY, 2011, 24 (01) : 86 - 91
  • [42] Blood purification in end-stage heart failure: a study in 16 patients
    Masahiko, K. Kitada
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 381 - 381
  • [43] Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure
    O'Dell, KM
    Kalus, JS
    Kucukarslan, S
    Czerska, B
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (06) : 606 - 609
  • [44] Heme Levels Are Increased in the Hearts of Patients with End-Stage Heart Failure
    Khechaduri, Arineh
    Bayeva, Marina
    Ardehali, Hossein
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [45] Increased expression of cardiac phosphatases in patients with end-stage heart failure
    Neumann, J
    Eschenhagen, T
    Jones, LR
    Linck, B
    Schmitz, W
    Scholz, H
    Zimmermann, N
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (01) : 265 - 272
  • [46] Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
    Nagaraju, Chandan K.
    Robinson, Emma L.
    Abdesselem, Mouna
    Trenson, Sander
    Dries, Eef
    Gilbert, Guillaume
    Janssens, Stefan
    Van Cleemput, Johan
    Rega, Filip
    Meyns, Bart
    Roderick, H. Llewelyn
    Driesen, Ronald B.
    Sipido, Karin R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (18) : 2267 - 2282
  • [47] Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure?
    Chachques, Juan Carlos
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 35 (02) : 201 - 203
  • [48] Evaluation of heart failure therapy in patients with end-stage renal disease
    Cutshall, Tate
    Duhart, Benjamin T., Jr.
    Saikumar, Jagannath
    Samarin, Michael
    Hutchison, Lydia
    Hudson, Joanna
    PHARMACOTHERAPY, 2016, 36 (12): : E256 - E256
  • [49] Liver function tests and hemodynamics in end-stage heart failure patients
    Mariacher, S.
    Mussner-Seeber, C.
    Lorsbach-Koehler, A.
    Hoefer, D.
    Antretter, H.
    Frick, M.
    Poelzl, G.
    EUROPEAN HEART JOURNAL, 2010, 31 : 278 - 278
  • [50] Short-term mortality in end-stage heart failure patients
    Maria Verdu-Rotellar, Jose
    Calero, Esther
    Abellana, Rosa
    Verdu-Soriano, Jose
    Vinyoles, Ernest
    Luis del Val-Garcia, Jose
    Domingo, Mar
    Munoz, Miguel-Angel
    ATENCION PRIMARIA, 2020, 52 (07): : 477 - 487
12345